Paolo Calabria

Showing 1-2 of 2 articles

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_01

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print: OCT findings in ESR

Jincheng Guo et al.

February 24, 2021

Consolidating the value of the standardised ARC-HBR definition

Giuseppe Gargiulo et al.

February 24, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..

February 16, 2021

European position paper on PFO – Part II

Christian Pristipino et al.

January 28, 2021

Valvular disease